Open AccessMacrometastasis at selective lymph node biopsy: A practical going-for-the-one clinical scoring system to personalize decision making
Author(s) -
Mercedes Herrero,
R. Ciérvide,
Maria Elisa Calle-Purón,
J. Martín-Calama Valero,
Paula Buelga,
Isabel Rodriguez-Bertos,
Leticia Benassi,
Á. Montero
Publication year - 2021
Publication title -
world journal of clinical oncology
Language(s) - English
Resource type - Journals
ISSN - 2218-4333
DOI - 10.5306/wjco.v12.i8.675
Subject(s) - medicine , biopsy , micrometastasis , clinical decision making , lymph node , sentinel lymph node , lymph , oncology , medical physics , radiology , intensive care medicine , pathology , cancer , metastasis , breast cancer
Axillary sentinel lymph node biopsy (SLNB) is standard treatment for patients with clinically and pathological negative lymph nodes. However, the role of completion axillary lymph node dissection (cALND) following positive sentinel lymph node biopsy (SLNB) is debated.